NASDAQ-Listed Company Silo Pharma Announces First Purchase of RSC Tokens

BlockBeats News, October 6 – According to official reports, Silo Pharma, Inc. (NASDAQ: SILO), a diversified biopharmaceutical and cryptocurrency treasury management company, announced today its first purchase of ResearchCoin (RSC). This move is a significant step in expanding its digital asset treasury strategy, aiming to capture long-term value from emerging multi-chain opportunities. RSC is the native token of ResearchHub, a decentralized scientific collaboration platform co-founded in 2019 by Coinbase CEO Brian Armstrong. Eric Weisblum, CEO of Silo Pharma, stated: "By investing in RSC, we are not only participating in the rapidly growing decentralized science (DeSci) movement but also diversifying assets and creating potential value for our shareholders. Our investment in ResearchCoin underscores our focus on modernizing scientific collaboration and our support for blockchain-driven innovation as a cornerstone of biomedical discovery."